A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine
Although treatment options for melanoma patients have expanded in recent years with the approval of immunotherapy and targeted therapy, there is still an unmet need for new treatment options for patients that are ineligible for, or resistant to these therapies. BH3 mimetics, drugs that mimic the act...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI AG
2021-07-01
|
| 叢編: | Pharmaceuticals |
| 主題: | |
| 在線閱讀: | https://www.mdpi.com/1424-8247/14/8/749 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|